Oppenheimer & CO Inc Pds Biotechnology Corp Transaction History

Oppenheimer & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$3.05 - $6.68 $8,387 - $18,370	-2,750 Reduced 11.0%	22,250 $81,000
Q1 2022 May 12, 2022	BUY	$4.78 - $8.43 $52,580 - $92,730	11,000 Added 78.57%	25,000 $155,000
Q4 2021 Feb 02, 2022	BUY	$7.76 - $14.35 $10,476 - $19,372	1,350 Added 10.67%	14,000 $114,000
Q3 2021 Nov 12, 2021	BUY	$9.33 - $17.08 $933 - $1,707	100 Added 0.8%	12,650 $188,000
Q2 2021 Aug 03, 2021	BUY	$4.35 - $12.86 $54,592 - $161,393	12,550 New	12,550 $158,000

4.05M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $42.7M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.